B. Lin Quek

Novopyxis, Inc.

$248,396

Attributed

$496,791

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $248.6K · FY2018–20

$250K$187.5K$125K$62.5K$0

'18

'19

'20

Funding mix

By agency

NIH$496,791 · 1

By mechanism

R43$496,791 · 1

Top collaborators

Rathi Srinivas2 shared

Most similar at Novopyxis, Inc.

Same institution · by research overlap

Rathi Srinivas$248,396

Others in their field

Other Emerging Leaders on “Mucous Membrane”

Ted Ross · University Of Georgia$71,962,304
Gary Fanger · Rise Therapeutics, Llc$25,549,931
Thomas Denny · Duke University$19,381,749
Donna Muzny · Baylor College Of Medicine$7,660,082
Matthew R Vogt · Univ Of North Carolina Chapel Hill$6,321,860
Namita Rout · Tulane University Of Louisiana$6,177,874

Research focus

Mucous MembraneStratum BasaleGene ExpressionMonolayerPreventResponseDrug EfficacyFda ApprovedLegal PatentMessenger RnaPlasmidsPressurePumpRespiratory DiaphragmDevicesCellsEpidermolysis BullosaEpithelialGenetic DiseasesIn VivoBaseLiquid SubstanceOther GeneticsSubmicron

Grant awards (2)

Droplette: A Platform Technology for At-Home, Effective, and Rapid Pulmonary Delivery to Reduce Ventilator Use & Hospitalization$248,206

R43 · FY2020 · EB

Droplette: A Platform Technology to Deliver Nucleic Acid Therapeutics Deep into Tissue for the Treatment of Epidermolysis Bullosa and Other Genetic Diseases$248,585

R43 · FY2018 · EB